These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 14219941)

  • 81. Control of respiratory disease in recruits with types 4 and 7 adenovirus vaccines.
    Top FH; Dudding BA; Russell PK; Buescher EL
    Am J Epidemiol; 1971 Aug; 94(2):142-6. PubMed ID: 4327997
    [No Abstract]   [Full Text] [Related]  

  • 82. Neutralizing antibodies against adenovirus type 2 in normal and HIV-1-infected subjects: Implications for use of Ad2 vectors in vaccines.
    Li Q; Liu Q; Huang W; Song A; Zhao C; Wu J; Wang Y
    Hum Vaccin Immunother; 2017 Jun; 13(6):1-8. PubMed ID: 28301274
    [TBL] [Abstract][Full Text] [Related]  

  • 83. [Vaccines and vaccination using live and inactivated viruses against pulmonary diseases in cattle].
    Soulebot JP; Petermann HG; Terré J; Brun A; Chappuis G; Thillerot M
    Vet Med Nauki; 1975; 12(3):53-6. PubMed ID: 164725
    [No Abstract]   [Full Text] [Related]  

  • 84. INFLUENCE OF HEAT INACTIVATION ON THE NEUTRALIZATION OF TYPE 7 ADENOVIRUS BY ANIMAL SERA.
    SVARTZ-MALMBERG G
    Acta Pathol Microbiol Scand; 1964; 60():295-6. PubMed ID: 14121987
    [No Abstract]   [Full Text] [Related]  

  • 85. Recombinant FAdV-4 fiber-2 protein protects chickens against hepatitis-hydropericardium syndrome (HHS).
    Schachner A; Marek A; Jaskulska B; Bilic I; Hess M
    Vaccine; 2014 Feb; 32(9):1086-92. PubMed ID: 24397897
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Serological identification of an Australian adenovirus isolate from sheep.
    Adair BM; McKillop ER; Coackley BH
    Aust Vet J; 1986 May; 63(5):162. PubMed ID: 3019292
    [No Abstract]   [Full Text] [Related]  

  • 87. [A CASE OF ADENOVIRUS TYPE 4 INFECTION WITH A SEVERE CLINICAL COURSE].
    WANKOWICZ R; IMBS D
    Pediatr Pol; 1965 Mar; 40():301-3. PubMed ID: 14332795
    [No Abstract]   [Full Text] [Related]  

  • 88. Adenovirus neutralization--behavior of virion derived capsid components in the production of in vitro neutralizing antibody.
    Shortridge KF
    Microbios; 1972; 5(20):265-72. PubMed ID: 4673679
    [No Abstract]   [Full Text] [Related]  

  • 89. Persistence in humans of antibody after immunization with four alphavirus vaccines.
    DeMeio JL; DeSanctis AN; Thomas WJ
    Asian J Infect Dis; 1979 Sep; 3(3):119-24. PubMed ID: 233418
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Role of adenovirus antigens in the induction of virus neutralizing antibody.
    Kjellén L; Pereira HG
    J Gen Virol; 1968 Jan; 2(1):177-85. PubMed ID: 4967084
    [No Abstract]   [Full Text] [Related]  

  • 91. Dual infection of hamsters with Adenovirus type 12 and type 6.
    Yabe Y
    Gan; 1974 Aug; 65(4):331-5. PubMed ID: 4372120
    [No Abstract]   [Full Text] [Related]  

  • 92. [Serological response of rabbits following immunization with M. parainfluenzae-3, adenovirus I and infectious bovine rhinotracheitis virus associated antigens].
    Tsvetkov P
    Vet Med Nauki; 1977; 14(6):33-6. PubMed ID: 202065
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Adenovirus 2, Bordetella bronchiseptica, and Parainfluenza Molecular Diagnostic Assay Results in Puppies After vaccination with Modified Live Vaccines.
    Ruch-Gallie R; Moroff S; Lappin MR
    J Vet Intern Med; 2016; 30(1):164-6. PubMed ID: 26692461
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Live vaccines against influenza, adenoviruses, measles, and mumps.
    Smorodintsev AA; Alexandrova GI; Boychuck LM; Nasibov MN; Selivanov AA; Taros LY
    Arch Environ Health; 1969 Jan; 18(1):105-14. PubMed ID: 4302157
    [No Abstract]   [Full Text] [Related]  

  • 95. EXPERIMENTAL ENTERIC INFECTION OF CHICKENS WITH AN AVIAN ADENO-VIRUS (STRAIN 93).
    CLEMMER DL
    Proc Soc Exp Biol Med; 1965 Apr; 118():943-8. PubMed ID: 14277716
    [No Abstract]   [Full Text] [Related]  

  • 96. Epidemic occurrence of adenovirus type 7 infection in Helsinki.
    JANSSON E; WAGER O; FORSSELL P; STENSTROM R
    Ann Paediatr Fenn; 1962; 8():24-34. PubMed ID: 14451250
    [No Abstract]   [Full Text] [Related]  

  • 97. Broad blockade antibody responses in human volunteers after immunization with a multivalent norovirus VLP candidate vaccine: immunological analyses from a phase I clinical trial.
    Lindesmith LC; Ferris MT; Mullan CW; Ferreira J; Debbink K; Swanstrom J; Richardson C; Goodwin RR; Baehner F; Mendelman PM; Bargatze RF; Baric RS
    PLoS Med; 2015 Mar; 12(3):e1001807. PubMed ID: 25803642
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Search for illness due to adenovirus type 4 among college dormitory freshmen.
    KATZ S; BADGER F; DENISON AB; DENNY FW; JORDAN WS
    Proc Soc Exp Biol Med; 1959; 101():592-4. PubMed ID: 14404817
    [No Abstract]   [Full Text] [Related]  

  • 99. Antibody response in rabbits to adenovirus type 12.
    RAFAJKO RR
    Proc Soc Exp Biol Med; 1963 May; 113():238-40. PubMed ID: 13990410
    [No Abstract]   [Full Text] [Related]  

  • 100. Antigenicity of adenovirus type 4 soluble antigens in man.
    Kasel JA; Banks PA; Huber M; Alford RH; Knight V
    J Bacteriol; 1966 Jan; 91(1):464. PubMed ID: 5903112
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.